The best peptides for skin, ranked on controlled human data
Cosmetic peptides are the one corner of this field where controlled human trials are common, because the cosmetics industry runs them. These are ranked on that data, and the ranking does not match the marketing budgets.
Quick answer
| # | Compound | Class | Evidence | Reported range | Status |
|---|---|---|---|---|---|
| 1 | GHK-Cu | Healing & repair | Clinical trials | 1-2 mg | Unapproved |
| 2 | Matrixyl | Cosmetic & topical | Clinical trials | 3-8 mg | Unapproved |
| 3 | Argireline | Cosmetic & topical | Clinical trials | 5-10 mg | Unapproved |
| 4 | Decapeptide-12 | Cosmetic & topical | Clinical trials | 1 mg | Unapproved |
| 5 | Palmitoyl Tetrapeptide-7 | Cosmetic & topical | Preliminary human | 1-4 mg | Unapproved |
The ranking
The copper tripeptide, with controlled human trials showing collagen and elastin stimulation and improvement in photoaged skin. The deepest evidence base in cosmetic peptides.
Palmitoyl pentapeptide-4, a collagen fragment that signals fibroblasts to synthesise more. Split-face controlled trials show measurable wrinkle-depth reduction. One of very few cosmetic actives with that standard of evidence.
The topical SNARE-complex inhibitor marketed as botox in a bottle. Human trials show modest expression-line reduction. The botulinum comparison is marketing; the effect is real but small.
A tyrosinase inhibitor for hyperpigmentation with controlled human trials against hydroquinone. Slower, but without the melanocyte cytotoxicity. The right choice for melasma if a peptide is wanted.
The anti-inflammatory half of Matrixyl 3000. Reduces IL-6 and glycation-driven ageing. Rarely studied alone, which is why it ranks below its partner.
What we left out, and why
- SNAP-8
- An elongated Argireline. Manufacturer data only; no independent comparison showing it outperforms the parent.
Head-to-head comparisons
References for the compounds in this guide
- Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.Int J Mol Sci 2018.PubMed 29986520 · doi:10.3390/ijms19071987
- GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.Biomed Res Int 2015.PubMed 26236730 · doi:10.1155/2015/648108
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.Am J Sports Med 2026.PubMed 41476424 · doi:10.1177/03635465251357593
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.J Am Acad Orthop Surg Glob Res Rev 2026.PubMed 41490200 · doi:10.5435/JAAOSGlobal-D-25-00236
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.Sports Med 2026.PubMed 41966639 · doi:10.1007/s40279-026-02437-0
- Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?.Molecules 2025.PubMed 39795193 · doi:10.3390/molecules30010136
- The human tri-peptide GHK and tissue remodeling.J Biomater Sci Polym Ed 2008.PubMed 18644225 · doi:10.1163/156856208784909435
- Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives.Int J Mol Sci 2026.PubMed 42123471 · doi:10.3390/ijms27093890
- Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?.Strahlenther Onkol 2004.PubMed 15127162 · doi:10.1007/s00066-004-1174-9
- Efficacy of anti-aging products for periorbital wrinkles as measured by 3-D imaging.J Cosmet Dermatol 2009.PubMed 19735523 · doi:10.1111/j.1473-2165.2009.00444.x
- Application of genomics to breakthroughs in the cosmetic treatment of skin ageing and discoloration.Br J Dermatol 2012.PubMed 22670614 · doi:10.1111/j.1365-2133.2012.10960.x
- Cosmeceuticals in photoaging: A review.Skin Res Technol 2024.PubMed 39233460 · doi:10.1111/srt.13730
- Acetyl Hexapeptide-8 in Cosmeceuticals-A Review of Skin Permeability and Efficacy.Int J Mol Sci 2025.PubMed 40565185 · doi:10.3390/ijms26125722
- Complications and adverse effects of periocular aesthetic treatments.Surv Ophthalmol 2022.PubMed 33933438 · doi:10.1016/j.survophthal.2021.04.009
- Facial rejuvenation: combining cosmeceuticals with cosmetic procedures.Cutis 2014.PubMed 25279473
- The landscape of serum autoantibodies in lupus nephritis.Autoimmun Rev 2026.PubMed 42409299 · doi:10.1016/j.autrev.2026.104128
- The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study.Am J Clin Dermatol 2013.PubMed 23417317 · doi:10.1007/s40257-013-0009-9
- Cyclosporine toxicity in renal transplant recipients detected by nailfold capillaroscopy with Na-fluorescein.Kidney Int 2000.PubMed 11115091 · doi:10.1046/j.1523-1755.2000.00441.x
- Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis.Vaccine 2017.PubMed 27939013 · doi:10.1016/j.vaccine.2016.11.013
- A split-face, double-blind, randomized and placebo-controlled pilot evaluation of a novel oligopeptide for the treatment of recalcitrant melasma.J Drugs Dermatol 2009.PubMed 19663110
- Open-label evaluation of the skin-brightening efficacy of a skin-brightening system using decapeptide-12.J Cosmet Laser Ther 2012.PubMed 22401652 · doi:10.3109/14764172.2012.672745
- Open-label evaluation of a novel skin brightening system containing 0.01% decapeptide-12 in combination with 20% buffered glycolic acid for the treatment of mild to moderate facial melasma.J Drugs Dermatol 2013.PubMed 23839199
- The nucleoprotein of influenza A virus inhibits the innate immune response by inducing mitophagy.Autophagy 2023.PubMed 36588386 · doi:10.1080/15548627.2022.2162798
- Comprehensive evaluation of the efficacy and safety of a new multi-component anti-aging topical eye cream.Skin Res Technol 2024.PubMed 38932444 · doi:10.1111/srt.13790
Literature retrieved from PubMed on October 16, 2026, favouring human studies and reviews. Numbered markers in the text show which paper supports which statement; uncited entries are background reading.